Cutting Edge Gene Therapies: Beta-Thalassemia Breakthroughs (Part I) – Seeking Alpha
Seeking Alpha |
Cutting Edge Gene Therapies: Beta-Thalassemia Breakthroughs (Part I)
Seeking Alpha There have been many gene therapy companies which have arisen over the past decade to treat beta-thalassemia. This devastating illness results in very high lifetime costs (upwards of $1 million) and an estimated 60,000 patients which currently have a … |
